UY34552A - Forma cristalina delta de la sal de arginina de perindoprilo, su procedimiento de preparación, y las composiciones farmacéuticas que la contienen - Google Patents

Forma cristalina delta de la sal de arginina de perindoprilo, su procedimiento de preparación, y las composiciones farmacéuticas que la contienen

Info

Publication number
UY34552A
UY34552A UY0001034552A UY34552A UY34552A UY 34552 A UY34552 A UY 34552A UY 0001034552 A UY0001034552 A UY 0001034552A UY 34552 A UY34552 A UY 34552A UY 34552 A UY34552 A UY 34552A
Authority
UY
Uruguay
Prior art keywords
perindoprile
pharmaceutical compositions
compositions containing
crystal form
preparation procedure
Prior art date
Application number
UY0001034552A
Other languages
English (en)
Inventor
Linol Julie
Laurent Stephane
Grenier Arnaud
Mathieu Sebastien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47427277&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY34552(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of UY34552A publication Critical patent/UY34552A/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B43/00—Forming, feeding, opening or setting-up containers or receptacles in association with packaging
    • B65B43/42—Feeding or positioning bags, boxes, or cartons in the distended, opened, or set-up state; Feeding preformed rigid containers, e.g. tins, capsules, glass tubes, glasses, to the packaging position; Locating containers or receptacles at the filling position; Supporting containers or receptacles during the filling operation
    • B65B43/46—Feeding or positioning bags, boxes, or cartons in the distended, opened, or set-up state; Feeding preformed rigid containers, e.g. tins, capsules, glass tubes, glasses, to the packaging position; Locating containers or receptacles at the filling position; Supporting containers or receptacles during the filling operation using grippers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G47/00—Article or material-handling devices associated with conveyors; Methods employing such devices
    • B65G47/74—Feeding, transfer, or discharging devices of particular kinds or types
    • B65G47/90—Devices for picking-up and depositing articles or materials
    • B65G47/91—Devices for picking-up and depositing articles or materials incorporating pneumatic, e.g. suction, grippers
    • B65G47/912—Devices for picking-up and depositing articles or materials incorporating pneumatic, e.g. suction, grippers provided with drive systems with rectilinear movements only
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G2201/00—Indexing codes relating to handling devices, e.g. conveyors, characterised by the type of product or load being conveyed or handled
    • B65G2201/02—Articles
    • B65G2201/0235—Containers

Abstract

Forma cristalina delta del compuesto de fórmula (I) caracterizada por su diagrama de difracción X sobre polvo. Medicamentos.
UY0001034552A 2012-01-05 2012-12-27 Forma cristalina delta de la sal de arginina de perindoprilo, su procedimiento de preparación, y las composiciones farmacéuticas que la contienen UY34552A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1200033A FR2985511B1 (fr) 2012-01-05 2012-01-05 Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
UY34552A true UY34552A (es) 2013-07-31

Family

ID=47427277

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034552A UY34552A (es) 2012-01-05 2012-12-27 Forma cristalina delta de la sal de arginina de perindoprilo, su procedimiento de preparación, y las composiciones farmacéuticas que la contienen

Country Status (43)

Country Link
US (1) US8835652B2 (es)
EP (1) EP2612850B1 (es)
JP (1) JP5722923B2 (es)
KR (1) KR101502945B1 (es)
CN (1) CN103193864B (es)
AP (1) AP2013006657A0 (es)
AR (1) AR089631A1 (es)
AU (1) AU2012268815B2 (es)
CA (1) CA2800946C (es)
CL (1) CL2013000021A1 (es)
CO (1) CO6700139A1 (es)
CR (1) CR20120655A (es)
CU (1) CU20130001A7 (es)
CY (1) CY1114704T1 (es)
DK (1) DK2612850T3 (es)
EA (1) EA022574B1 (es)
EC (1) ECSP13012365A (es)
ES (1) ES2439871T3 (es)
FR (1) FR2985511B1 (es)
GE (1) GEP20146182B (es)
GT (1) GT201300003A (es)
HK (1) HK1187061A1 (es)
HR (1) HRP20131164T1 (es)
IL (1) IL223752A (es)
JO (1) JO3084B1 (es)
MA (1) MA35002B1 (es)
MD (1) MD4350C1 (es)
MX (1) MX2013000013A (es)
MY (1) MY176877A (es)
NI (1) NI201200194A (es)
PE (1) PE20131327A1 (es)
PH (1) PH12012000393A1 (es)
PL (1) PL2612850T3 (es)
PT (1) PT2612850E (es)
RS (1) RS53001B (es)
SA (1) SA113340173B1 (es)
SG (1) SG192336A1 (es)
SI (1) SI2612850T1 (es)
TN (1) TN2012000619A1 (es)
TW (1) TWI471307B (es)
UA (1) UA111334C2 (es)
UY (1) UY34552A (es)
WO (1) WO2013102741A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
CN110283104B (zh) * 2018-08-22 2022-06-14 南京济群医药科技股份有限公司 一种精氨酸培哚普利的制备方法
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules
SI26268A (sl) 2021-11-18 2023-05-31 Zupet Rok Postopek za pripravo hidratirane oblike perindopril l-arginina
CN114149357A (zh) * 2021-12-29 2022-03-08 江苏嘉逸医药有限公司 一种γ晶型培哚普利精氨酸盐的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2620703B1 (fr) * 1987-09-17 1991-10-04 Adir Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides
JPH04352788A (ja) * 1990-08-30 1992-12-07 Kanebo Ltd 新規キノリンカルボン酸誘導体、該化合物を有効成分とする抗菌剤および該化合物の製造方法
EP0934941A1 (en) * 1996-08-09 1999-08-11 Eisai Co., Ltd. Benzopiperidine derivatives
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
JP4402361B2 (ja) * 2003-03-31 2010-01-20 大日本印刷株式会社 塩酸エピナスチンの結晶多形
CN101227902A (zh) * 2005-08-12 2008-07-23 桑多斯股份公司 培哚普利特丁胺的新结晶形式
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897866B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EP1864973A1 (en) * 2006-06-09 2007-12-12 Sochinaz SA Process for the preparation of perindopril and salts thereof
CN102015748B (zh) * 2008-04-01 2014-06-25 卢莫维塔有限公司 高纯戊霉素
WO2009157018A2 (en) * 2008-06-24 2009-12-30 Matrix Laboratories Ltd Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof
AU2009212902A1 (en) * 2008-09-03 2010-03-18 Apotex Pharmachem Inc. Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
SI23001A (sl) * 2009-03-20 2010-09-30 Diagen@d@o@o Nove soli perindoprila nov postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
CN102114017A (zh) * 2011-01-05 2011-07-06 王定豪 包含氨氯地平和培哚普利的药物组合物及其应用

Also Published As

Publication number Publication date
TWI471307B (zh) 2015-02-01
MD4350B1 (ro) 2015-05-31
JO3084B1 (ar) 2017-03-15
MY176877A (en) 2020-08-25
AR089631A1 (es) 2014-09-03
CU20130001A7 (es) 2014-08-28
CA2800946C (fr) 2014-07-15
MA35002B1 (fr) 2014-04-03
EA201201668A1 (ru) 2013-10-30
GEP20146182B (en) 2014-10-27
CA2800946A1 (fr) 2013-07-05
BR102013000161A2 (pt) 2015-05-12
TN2012000619A1 (fr) 2014-04-01
PH12012000393B1 (en) 2014-07-28
CR20120655A (es) 2013-03-05
HRP20131164T1 (hr) 2014-01-03
UA111334C2 (uk) 2016-04-25
AU2012268815A1 (en) 2013-07-18
CN103193864A (zh) 2013-07-10
KR101502945B1 (ko) 2015-03-16
TW201331178A (zh) 2013-08-01
SA113340173B1 (ar) 2015-07-09
RS53001B (en) 2014-04-30
PE20131327A1 (es) 2013-11-15
DK2612850T3 (da) 2013-12-16
KR20130080814A (ko) 2013-07-15
EP2612850A1 (fr) 2013-07-10
JP5722923B2 (ja) 2015-05-27
JP2013139444A (ja) 2013-07-18
PH12012000393A1 (en) 2014-07-28
PL2612850T3 (pl) 2014-01-31
IL223752A0 (en) 2013-07-31
CY1114704T1 (el) 2016-10-05
ES2439871T3 (es) 2014-01-27
ECSP13012365A (es) 2013-04-30
EP2612850B1 (fr) 2013-09-18
MX2013000013A (es) 2013-07-15
SG192336A1 (en) 2013-08-30
IL223752A (en) 2016-08-31
HK1187061A1 (en) 2014-03-28
FR2985511A1 (fr) 2013-07-12
CN103193864B (zh) 2014-09-17
SI2612850T1 (sl) 2014-01-31
GT201300003A (es) 2014-03-14
CO6700139A1 (es) 2013-06-28
CL2013000021A1 (es) 2014-07-18
PT2612850E (pt) 2013-11-21
NZ605264A (en) 2013-12-20
US8835652B2 (en) 2014-09-16
FR2985511B1 (fr) 2014-01-03
AP2013006657A0 (en) 2013-01-31
WO2013102741A1 (fr) 2013-07-11
US20130178464A1 (en) 2013-07-11
EA022574B1 (ru) 2016-01-29
MD4350C1 (ro) 2015-12-31
AU2012268815B2 (en) 2014-02-13
NI201200194A (es) 2013-05-13
MD20120130A2 (en) 2013-07-31

Similar Documents

Publication Publication Date Title
CY1120529T1 (el) Προφαρμακα φουμαρικων αλατων και η χρηση τους στην αγωγη ποικιλων νοσων
CY1124729T1 (el) Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου
PH12019500176A1 (en) Heterocyclic compounds and ther uses
UY34763A (es) Inhibidores de la agregación plaquetaria
CR20140576A (es) Sintesis de compuestos heterociclicos
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
CL2015000295A1 (es) Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades.
UY34220A (es) Indazoles, composiciones farmacéuticas y uso de los mismos
UY34545A (es) Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios.
UY35661A (es) Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que lo s contienen
DE202012013074U8 (de) Zusammensetzungen zur Behandlung von HCV
UY34542A (es) ?formulaciones farmacéuticas para conjugados de derivados de fumagilina y phf?.
NI201400079A (es) Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CL2015000408A1 (es) Compuestos derivados de pirazolo[4,3-d]pirimidina y sus sales; composicion farmaceutica que los comprende, util para el tratamiento de enfermedades alergicas, inflamatorias, infecciosas o cancer.
UY33863A (es) Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer
UY34541A (es) ?derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina?.
EA201691216A1 (ru) Композиции линаклотида с замедленным высвобождением
CL2015002488A1 (es) Sal de abexinostato novedosa, forma cristalina relacionada, método de preparación de esta y las composiciones farmacéuticas que la contienen
ECSP16074478A (es) Compuestos novedosos
UY34527A (es) ?composiciones, métodos y kits para la preparación de proteínas recombinantes sialiladas?.
UY34603A (es) Anticuerpos anti-asic-1 y usos de los mismos
UY34018A (es) Derivados glucósidos y usos de los mismos
UY34491A (es) La composición herbicida que contiene ácido de 4-amino-3-cloro-6- (4-cloro-2-flúor-3-metoxifenil) pyridina-2-carboxílico o los derivados de los mismos y fluroxipir o los derivados de los mismos
GT201500143A (es) Composiciones que comprenden vortioxetina y donepezilo campo tecnico
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20211122